Emerging moulds: epidemiological trends and antifungal resistance.
about
Bench-to-bedside review: Rapid molecular diagnostics for bloodstream infection--a new frontier?Transcriptional Control of Drug Resistance, Virulence and Immune System Evasion in Pathogenic Fungi: A Cross-Species ComparisonAn automated high-throughput cell-based multiplexed flow cytometry assay to identify novel compounds to target Candida albicans virulence-related proteinsSuppression of sensitivity to drugs and antibiotics by high external cation concentrations in fission yeastNFAP2, a novel cysteine-rich anti-yeast protein from Neosartorya fischeri NRRL 181: isolation and characterizationIn vitro and in vivo activities of pterostilbene against Candida albicans biofilms.Invasive fungal infections in transplant recipientsZinc and Manganese Chelation by Neutrophil S100A8/A9 (Calprotectin) Limits Extracellular Aspergillus fumigatus Hyphal Growth and Corneal Infection.Mold contamination in a controlled hospital environment: a 3-year surveillance in southern Italy.MALDI-TOF mass spectrometry: any use for Aspergilli?Use of matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of molds of the Fusarium genus.Safety and efficacy of liposomal amphotericin B for the empirical therapy of invasive fungal infections in immunocompromised patients.Performance of Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry for Identification of Aspergillus, Scedosporium, and Fusarium spp. in the Australian Clinical Setting.Identification of Molds by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass SpectrometrySynthesis and Biological Evaluation of Novel 2-Aminonicotinamide Derivatives as Antifungal Agents.SIMIFF study: Italian fungal registry of mold infections in hematological and non-hematological patients.Safety of posaconazole.Scedosporium prolificans pericarditis and mycotic aortic aneurysm in a lung transplant recipient receiving voriconazole prophylaxis.Bone and joint infections by Mucorales, Scedosporium, Fusarium and even rarer fungi.Is the emergence of fungal resistance to medical triazoles related to their use in the agroecosystems? A mini review.Synergy between azoles and 1,4-dihydropyridine derivative as an option to control fungal infections.Fungal infection mimicking pulmonary malignancy: clinical and radiological characteristics.Risk Factors and Outcomes of Invasive Fungal Infections in Allogeneic Hematopoietic Cell Transplant Recipients.Evaluation of Antifungal Activity and Mode of Action of New Coumarin Derivative, 7-Hydroxy-6-nitro-2H-1-benzopyran-2-one, against Aspergillus spp.Ultraviolet induction of antifungal activity in plants.Susceptibility Testing of Common and Uncommon Aspergillus Species against Posaconazole and Other Mold-Active Antifungal Azoles Using the Sensititre Method.[Infections in hemato-oncology patients in intensive care. An interdisciplinary challenge].Isavuconazole and nine comparator antifungal susceptibility profiles for common and uncommon Candida species collected in 2012: application of new CLSI clinical breakpoints and epidemiological cutoff values.Does fungicide application in vineyards induce resistance to medical azoles in Aspergillus species?Detection of (1, 3)-β-D-glucan in bronchoalveolar lavage and serum samples collected from immunocompromised hosts.Rare arthroconidial fungi in clinical samples: Scytalidium cuboideum and Arthropsis hispanica.Evaluation of Etest performed in Mueller-Hinton agar supplemented with glucose for antifungal susceptibility testing of clinical isolates of filamentous fungi.
P2860
Q27003122-C65737D4-5B87-43C8-8486-3BC37E4D5370Q28079641-ADB94D96-23D2-4797-95CA-FC9666DCCC81Q28544418-9D66D357-DEE2-436B-84ED-3735F405960CQ28544788-CB724C05-3665-476C-B393-636954F7B894Q30393041-142C4958-4C59-48CE-9016-4B1D78C15BBFQ33622833-2166D606-B0A4-4B21-8D90-A3982D099162Q33695215-F1EC34D0-CCCF-4072-A1E4-A043812412B0Q34502181-8158E78C-E245-4EE5-BB3E-57E92D26B016Q34537609-355B11E8-0253-496C-B122-F37089C7365DQ35202737-919F09D1-3F4C-4FB4-A2CE-8934540A4494Q35438499-FB002A75-A994-4AF6-A500-D25D1E905541Q35715408-14523090-E3C4-41BC-8325-64A1DCF3044BQ36037566-98552306-5AE4-4DC8-B19F-B53A9F31F473Q36180756-6281CC4E-552E-486B-8E6A-D1577A9F55A9Q36245326-66F682F4-5F6E-48B4-BEF0-611A1366A752Q37530914-29C88E7A-1C78-4147-B691-5433F53848D8Q38077591-79B9B859-BDB7-429B-912F-AEB5ABA96B8CQ38079632-089B713E-4374-4D5E-90CB-A6AD97913C7EQ38210282-58F73044-6195-44DA-ABAC-97A40FE445EBQ38932794-AAA18473-8108-4321-82DB-25BFAB2873E4Q40167866-C48FC6CD-EA2A-4EE2-A531-CB495B008B8EQ40234389-10D62A67-ECE4-481F-BF6A-2BEB52273A0EQ40357629-BFE93E0A-4F05-4C31-AA7C-C762FA49C3B3Q41107710-A4F2F305-B639-48BD-BE70-732B4B161280Q44392467-0B98A362-5D2A-4A6A-91BB-E55186B2FC88Q45199703-EF07E95F-D379-45D0-B598-7CAF77BDAD23Q46164114-985DDECE-FA4C-4566-BB0C-08C561DC8149Q46876288-4D0FEE95-2B61-44C8-8A69-13948711BBC0Q46893764-0D88F857-F381-4160-9D12-762CAB462CBAQ47192822-A4599E9C-0FBA-4F59-8BA4-7B3F01CAA2EDQ48045239-CE5F469C-A7A9-474A-8CE5-5B43BDF0636FQ50718095-723913C3-B6DB-4DB6-98AB-7B8A83A2807E
P2860
Emerging moulds: epidemiological trends and antifungal resistance.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 14 June 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Emerging moulds: epidemiological trends and antifungal resistance.
@en
Emerging moulds: epidemiological trends and antifungal resistance.
@nl
type
label
Emerging moulds: epidemiological trends and antifungal resistance.
@en
Emerging moulds: epidemiological trends and antifungal resistance.
@nl
prefLabel
Emerging moulds: epidemiological trends and antifungal resistance.
@en
Emerging moulds: epidemiological trends and antifungal resistance.
@nl
P2860
P1433
P1476
Emerging moulds: epidemiological trends and antifungal resistance.
@en
P2093
Marisa H Miceli
Samuel A Lee
P2860
P304
P356
10.1111/J.1439-0507.2011.02032.X
P577
2011-06-14T00:00:00Z